Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AbbVie Oy
OY
Active
Y-tunnus 2470310-6
Pasilan Asema-Aukio 1, 00520
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2012
108 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AbbVie Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
BK
Baedr Kayali
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
BK
Bernd Krones
Chief Executive Officer
Chief Executive Officer
2023 – 2025
HR
Hanna Reetta Katariina Kaskimies
Audit
Audit
2013 – 2023
MR
Matthew Robert Iles
Chief Executive Officer
Chief Executive Officer
2019 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
PM
Päivi Margarita Kiiski
Board of Directors
2025
AJ
Arnaud Jean Jacques Coint-Bavarot
Board of Directors
2022
SI
Shitra Irari Amozurrutia
Board of Directors
2024
Former (4)
AK
Anne Katariina Lehtonen
Board of Directors
2018 – 2019
EC
Emilie Claudine Demare
Board of Directors
2022 – 2024
WJ
William Joseph Chase
Board of Directors
2018 – 2019
RA
Robert Andrew Michael
Board of Directors
2019 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AbbVie Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network